
Solutions OP Clinical Trials UK
Podcast de Olga Peycheva
Disfruta 14 días gratis
4,99 € / mes después de la prueba.Cancela cuando quieras.

Más de 1 millón de oyentes
Podimo te va a encantar, y no sólo a ti
Valorado con 4,7 en la App Store
Acerca de Solutions OP Clinical Trials UK
This podcast is dedicated to clinical trials and clinical research. We will be discussing different hot topics and analysis of the latest developments in clinical trials in pharmaceutical and medical devices industries. We have interviews with different industry experts.
Todos los episodios
29 episodios
Our latest episode is conversation with our Senior Clinical Data Quality Manager, Lydia Ainsworth, in which we discuss clinical research as a career choice and we give advice to graduates who are interested to work in the field. We cover topics like how to gain experience in clinical research, what universities can do to increase awareness in clinical research as career, if you need degree in biology to work in clinical research, some CV creation tips and many others.

This episode provides overview of the new clinical trials regulations in the UK which was signed into a law in April 2025. It highlights the main changes of the regulations and provides some background information what triggered these changes.

This episode is dedicated to the benefits of self-managed clinical trials for pharma startups. It discusses some of the complex issues that startups face with fully outsourcing clinical trials to clinical research organisations. It also covers what could companies do instead of fully outsourcing clinical trials and how this could help them in a long run.

This episode discusses the challenges of patients involvement in clinical trials design and documents review. While patients' contribution to clinical research is often important is some cases it could be very limited. On the other hand there is a growing reliance from the regulatory agencies on patients' involvement to review informed consents which brings additional complications.

This episode covers the reasons for red tape in the pharma industry and how to improve the interactions between the pharma industry and the regulators. The answer to the question who is responsible for the increasing red tape in the drug development is not simple but both the regulators and the pharma industry have to admit their contribution.

Valorado con 4,7 en la App Store
Disfruta 14 días gratis
4,99 € / mes después de la prueba.Cancela cuando quieras.
Podcasts exclusivos
Sin anuncios
Podcast gratuitos
Audiolibros
20 horas / mes